Cargando…
Semaphorin 7a is a biomarker for recurrence in postpartum breast cancer
Breast cancer is a global health threat and cases diagnosed in women during the years after childbirth, or postpartum breast cancers (PPBCs), have high risk for metastasis. In preclinical murine models, semaphorin 7a (SEMA7A) drives the metastatic potential of postpartum mammary tumors. Thus, we hyp...
Autores principales: | Borges, Virginia F., Hu, Junxiao, Young, Chloe, Maggard, Jaron, Parris, Hannah J., Gao, Dexiang, Lyons, Traci R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572422/ https://www.ncbi.nlm.nih.gov/pubmed/33088913 http://dx.doi.org/10.1038/s41523-020-00198-1 |
Ejemplares similares
-
Postpartum breast cancer progression is driven by semaphorin 7a mediated invasion and survival
por: Tarullo, Sarah E, et al.
Publicado: (2020) -
Hormonal Regulation of Semaphorin 7a Promotes Therapeutic Resistance in Breast Cancer
por: Crump, Lyndsey, et al.
Publicado: (2021) -
Semaphorin 7a exerts pleiotropic effects to promote breast tumor progression
por: Black, Sarah, et al.
Publicado: (2016) -
457 Semaphorin7a expression in breast cancer promotes susceptibility to immune checkpoint blockade
por: Elder, Alan, et al.
Publicado: (2022) -
437 Novel Targeting of Semaphorin 7a-Mediated Survival Signaling in ER+ Breast Cancer to Mitigate Therapy Resistance
por: Steinmetz, Rachel, et al.
Publicado: (2023)